Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 82251-82300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05398783
A Natural History Study of Metabolic Sizing in Health and Disease
N/A
Recruiting
2,000 participants
Started: Oct 25, 2022 · Completed: Jul 1, 2031
5 conditions
1 sponsor
1 location
NCT05458908
ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS
NA
Recruiting
252 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
14 locations
NCT04909073
Observational Study of Afatinib 30 mg Daily
N/A
Recruiting
69 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06337019
The Italian Registry of Malnutrition in Oncology
N/A
Recruiting
1,500 participants
Started: Oct 25, 2022 · Completed: Oct 31, 2027
2 conditions
2 sponsors
16 locations
NCT05804344
Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning
NA
Recruiting
100 participants
Started: Oct 25, 2022 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT06011018
Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke
NA
Recruiting
72 participants
Started: Oct 25, 2022 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT05745389
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
N/A
Recruiting
5,000 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2099
1 condition
1 sponsor
1 location
NCT05644756
Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments
NA
Active, not recruiting
76 participants
Started: Oct 25, 2022 · Completed: Aug 31, 2025
1 condition
3 sponsors
1 location
NCT05610098
Gene Expression Profiles in Spinal Tuberculosis.
N/A
Recruiting
100 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2026
14 conditions
2 sponsors
1 location
NCT05608096
European Registry for Hemadsorption in Sepsis With the Seraph Filter
N/A
Recruiting
300 participants
Started: Oct 25, 2022 · Completed: Dec 30, 2025
7 conditions
2 sponsors
1 location
NCT05453968
Berotralstat Treatment in Children With Hereditary Angioedema
PHASE3
Active, not recruiting
29 participants
Started: Oct 25, 2022 · Completed: Feb 28, 2027
2 conditions
1 sponsor
15 locations
NCT05423210
Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
EARLY_PHASE1
Recruiting
12 participants
Started: Oct 25, 2022 · Completed: Aug 31, 2029
1 condition
2 sponsors
1 location
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
PHASE3
Recruiting
1,590 participants
Started: Oct 25, 2022 · Completed: Oct 28, 2033
1 condition
1 sponsor
235 locations
NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
PHASE1
Recruiting
315 participants
Started: Oct 25, 2022 · Completed: Apr 8, 2028
7 conditions
1 sponsor
56 locations
NCT05479994
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2
Active, not recruiting
100 participants
Started: Oct 24, 2022 · Completed: Aug 25, 2027
5 conditions
1 sponsor
50 locations
NCT05591586
Mobile Video Interpretation to Optimize Communication Across Language Barriers
NA
Enrolling by invitation
6,669 participants
Started: Oct 24, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT04923178
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
N/A
Recruiting
1,100 participants
Started: Oct 24, 2022 · Completed: Dec 1, 2042
5 conditions
1 sponsor
1 location
NCT05465096
Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.
NA
Active, not recruiting
30 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05952310
Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas
NA
Recruiting
10 participants
Started: Oct 24, 2022 · Completed: Oct 24, 2029
1 condition
1 sponsor
1 location
NCT05466383
Screening and Intervention for AIS in Haikou, Hainan Province, China
NA
Recruiting
5,000 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05505916
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
PHASE3
Active, not recruiting
145 participants
Started: Oct 24, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
71 locations
NCT05491915
The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain
NA
Active, not recruiting
50 participants
Started: Oct 24, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
10 locations
NCT05439759
Factors in Learning and Plasticity: Healthy Vision
NA
Recruiting
120 participants
Started: Oct 24, 2022 · Completed: Nov 30, 2026
2 conditions
2 sponsors
2 locations
NCT06046365
Early Diagnosis of Breast Cancer-related Lymphedema
N/A
Recruiting
300 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05540860
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
PHASE2
Active, not recruiting
76 participants
Started: Oct 24, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
14 locations
NCT05586321
Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
26 participants
Started: Oct 24, 2022 · Completed: Oct 21, 2025
1 condition
2 sponsors
7 locations
NCT05601284
Psychological Intervention for Misophonia
NA
Active, not recruiting
60 participants
Started: Oct 24, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05601141
Clinics and Epidemiology of Pituitary Diseases in Modena Area Population
N/A
Recruiting
1,500 participants
Started: Oct 24, 2022 · Completed: Oct 24, 2031
1 condition
1 sponsor
1 location
NCT05213936
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
NA
Recruiting
30 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05600946
Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
N/A
Recruiting
19 participants
Started: Oct 24, 2022 · Completed: Sep 1, 2026
3 conditions
2 sponsors
1 location
NCT05506878
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
NA
Recruiting
286 participants
Started: Oct 24, 2022 · Completed: Sep 30, 2026
5 conditions
3 sponsors
4 locations
NCT05157620
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
NA
Recruiting
112 participants
Started: Oct 24, 2022 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT05387525
A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
PHASE4
Active, not recruiting
447 participants
Started: Oct 24, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
49 locations
NCT05511922
PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
PHASE3
Active, not recruiting
11 participants
Started: Oct 24, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
61 locations
NCT07190781
Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy
N/A
Enrolling by invitation
280 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2026
1 condition
5 sponsors
1 location
NCT06376448
An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
N/A
Recruiting
60 participants
Started: Oct 24, 2022 · Completed: Dec 10, 2025
1 condition
1 sponsor
1 location
NCT05358067
Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact
N/A
Recruiting
241 participants
Started: Oct 24, 2022 · Completed: Apr 24, 2027
1 condition
2 sponsors
5 locations
NCT05358249
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Oct 24, 2022 · Completed: May 18, 2026
11 conditions
1 sponsor
13 locations
NCT05139784
BeAT1D: Benign Autoimmunity and Type 1 Diabetes
N/A
Recruiting
740 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
17 locations
NCT05570578
Effects of Transcranial Direct Current Stimulation (tDCS) on Brain Organization and Naming in Aphasic Patients.
NA
Recruiting
14 participants
Started: Oct 24, 2022 · Completed: Apr 1, 2026
2 conditions
1 sponsor
1 location
NCT05311956
Pain Reduction Using NEurostimulation Study
NA
Recruiting
125 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2027
2 conditions
5 sponsors
2 locations
NCT05438212
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
PHASE3
Recruiting
236 participants
Started: Oct 24, 2022 · Completed: Mar 16, 2027
1 condition
2 sponsors
215 locations
NCT05552664
The Genetic Information and Family Testing (GIFT) Study
NA
Enrolling by invitation
5,614 participants
Started: Oct 24, 2022 · Completed: Oct 31, 2026
1 condition
2 sponsors
4 locations
NCT04373317
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
PHASE4
Recruiting
358 participants
Started: Oct 24, 2022 · Completed: Aug 24, 2027
1 condition
1 sponsor
24 locations
NCT05286814
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
PHASE2
Recruiting
70 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2028
8 conditions
1 sponsor
1 location
NCT05410418
Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma
PHASE2
Active, not recruiting
34 participants
Started: Oct 24, 2022 · Completed: May 31, 2031
2 conditions
3 sponsors
1 location
NCT05603468
Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair
PHASE4
Recruiting
387 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05583747
E-field Guided iTBS for Treatment Resistant Depression
NA
Recruiting
110 participants
Started: Oct 24, 2022 · Completed: Jul 31, 2027
1 condition
2 sponsors
2 locations
NCT05299879
Screening for Advanced Heart Failure IN Stable ouTpatientS - The SAINTS Study
N/A
Recruiting
400 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
PHASE3
Recruiting
400 participants
Started: Oct 24, 2022 · Completed: Jul 27, 2029
1 condition
1 sponsor
384 locations
Previous
1
More pages
1643
1644
1645
1646
1647
1648
1649
More pages
2369
Next